Nails News and Research

RSS

Personal usage and patient recommendations for dietary supplements are quite common across specialties

For physicians within several medical specialties, including dermatology, cardiology and orthopedics, personal usage of and patient recommendations for dietary supplements are quite common-, according to a study published in Nutrition Journal, a peer-reviewed, on-line journal that focuses on the field of human nutrition.

11 Mar 2011

EPO to grant patent for Apricus MycoVa product to treat nail fungus

Apricus Biosciences, Inc. announced today that the European Patent Office will grant a patent for the company's MycoVa product for treating onychomycosis.

2 Mar 2011

Patients receiving cancer treatment may experience skin, hair, nail problems

A cancer diagnosis and subsequent treatment, which commonly includes chemotherapy or radiation, can be taxing physically and emotionally on any patient. If that is not enough, dermatologists are cautioning patients receiving cancer treatment and cancer survivors that they may experience a host of skin, hair or nail problems as a direct result of their therapy that may require additional treatment by a dermatologist.

5 Feb 2011

Practice proper sun protection to reduce risk of future skin cancers, warn dermatologists

For many young adults, the serious health consequences of tanning have been shown to have little impact on their behavior when it comes to sun exposure. But with spring break around the corner, dermatologists are urging people -- particularly young adults -- to practice proper sun protection and understand the importance of early detection of skin cancer, the most common type of cancer.

5 Feb 2011

Apricus Bio's MycoVa demonstrates 'non-inferiority' for treatment of onychomycosis compared to Loceryl

Apricus Biosciences, Inc. today announced that an additional analysis conducted on behalf of the Company has shown that MycoVa™ has successfully demonstrated 'non-inferiority' for the treatment of onychomycosis (commonly referred to as nail fungus), compared to the current standard of care in Europe for topical therapy, Loceryl®.

20 Jan 2011

USDTL launches two new tests for monitoring long-term alcohol exposure using fingernail, hair specimens

United States Drug Testing Laboratories launched two new tests for monitoring long-term alcohol exposure on Friday. Using fingernail and hair specimens, the new assay is the first and only test to report a donor's alcohol exposure for the past 90 days reliably.

10 Jan 2011

PinPointe FootLaser receives FDA clearance for treatment of nail fungus

The podiatry practice of Mark E. Spier, DPM, announced today that the PinPointe™ FootLaser™ has received clearance from the U.S. Food and Drug Administration (FDA) for the treatment of nail fungus (onychomycosis). Dr. Spier is the first certified provider of the treatment in the Baltimore area.

26 Oct 2010

Hatch Medical signs agreement with Majid Shano to broker super-elastic orthopedic stapling technology

Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has recently entered into an agreement with Majid Shano MB, B.CH., (Munich, Germany) to broker his patented, super-elastic orthopedic stapling technology.

20 Sep 2010

Japanese plate and screw market to grow to over $170 million by 2014

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the Japanese plate and screw market will be driven by strong surgeon acceptance and adoption, driving this market to over $170 million by 2014.

2 Sep 2010

Dermatologist discusses on common nail ailment prevention

For many people, the phrase "tough as nails" doesn't apply to their own nails. Instead of strong nails, their nails may be brittle and break or split easily. Or, nail fungus might cause nails to look unattractive and unhealthy. Fortunately, dermatologists can help people improve the health and overall appearance of their nails with proper diagnosis and treatment.

6 Aug 2010

Female endurance sports athletes are at risk for serious health issues, say physicians

Female endurance sports athletes may be at risk for serious health issues, according to physicians at Loyola University Health System. Excessive exercise and inadequate nutrition can lead to problems such as low energy, menstrual irregularity, fertility issues, stress fractures and osteoporosis.

15 Jun 2010

Celtic Pharma commences enrolment in Phase III trial of TDT 067 for onychomycosis

Celtic Pharmaceutical Holdings L.P., the global private equity firm focused on the biotechnology and pharmaceutical industries, announced today the enrolment of the first patient into its Phase III trial of TDT 067, terbinafine in Transfersomes®, for the topical treatment of onychomycosis (also known as a fungal nail infection).

30 Apr 2010

Skin-colored hospital gowns can help detect cyanosis

Changing the hue of hospital gowns and bed sheets to match a patient's skin color could greatly enhance a physician's ability to detect cyanosis and other health-related skin color changes, according to a new study from Rensselaer Polytechnic Institute.

30 Apr 2010

Men who live further from cities more likely to have chronic health problems and higher death rates, says report

According to a new report from the Australian Institute of Health and Welfare, rural men are more prone to succumb to diseases like diabetes, some cancers like of head, neck and lip, poisonings and chronic health problems compared to those living in major cities.

14 Apr 2010

Uncertainties remain about health law

McClatchy/Miami Herald: "Two weeks after President Barack Obama signed the big health care overhaul into law, Americans are struggling to understand how — and when — the sweeping measure will affect them. Questions reflecting confusion have flooded insurance companies, doctors' offices, human resources departments and business groups." One insurance agent said consumers are asking, "Where do we get the free Obama care, and how do I sign up for that?" (Taley, 4/6).

8 Apr 2010

EvoLife Laboratories introduces cancer care products in USA

EvoLife Laboratories, a world leader in the development of products for skin, oral, nail, hair, hygiene care specifically designed for cancer patients undergoing chemotherapy and radiotherapy, announced the launch of its products in USA.

31 Mar 2010

Indoor tanning devices: AADA testifies before FDA panel on needed classification changes and calls for ban

American Academy of Dermatology Association (AADA) President and dermatologist William D. James, MD, FAAD, along with other dermatologists and leading researchers today testified before a Food and Drug Administration (FDA) panel considering changes to the current classification of indoor tanning devices. Currently, the FDA classifies indoor tanning devices as Class 1, the category for items that have minimal potential to cause harm to individuals. Items in Class 1 include adhesive bandages and tongue depressors.

27 Mar 2010

Childhood bad behaviour linked to chronic widespread pain in adult life

Bad behaviour in childhood is associated with long-term, chronic widespread pain in adult life, according to the findings of a study following nearly 20,000 people from birth in 1958 to the present day.

10 Mar 2010

Study sheds light on how CL-HA stimulates collagen repair in skin

In the U.S. and around the world, the popularity of minimally invasive cosmetic procedures continues to increase. Soft tissue injectables, also known as dermal fillers, are popular procedures that improve the appearance of aging and sun-damaged skin by restoring lost volume and filling lines.

5 Mar 2010

Dermatologist speaks about common forms of hair loss and treatment options at 68th Annual Meeting

For many women, unexplained hair loss can take a significant psychological toll on their overall quality of life. From altering their hairstyle to hide a thinning part to scaling back their hair care regimen in an effort to halt further hair loss, women try countless ways to cover up this problem - and the results are often lukewarm at best.

4 Mar 2010